The Lupus Academy

In this bonus episode our host Dr Raquel Faria discusses the SLE burden, scoring systems, patient education and novel treatment practice with Professors David Isenberg and Ricard Cervera of the Lupus Academy Steering Committee. Disclaimer: During Lupus Academy podcast episodes, participants may refer to off label use of medicines for patients with lupus. Lupus Academy does not make any recommendations about using a medicine outside the terms of its approved licence for use.

In this episode our host Dr Raquel Faria discusses two challenging cases with Professors David Isenberg and Ricard Cervera of the Lupus Academy Steering Committee. Case 1: Bone health and vitamin D in a 60-year-old Caucasian female Case 2: A long and complicated case history of idiopathic thrombocytopenic purpura (ITP) and recurrent fever. Disclaimer: ‘During Lupus Academy podcast episodes, participants may refer to off label use of medicines for patients with lupus. Lupus Academy does not make any recommendations about using a medicine outside the terms of its approved licence for use.’

In this episode our host Dr Raquel Faria discusses a challenging APS case with Professors David Isenberg and Ricard Cervera of the Lupus Academy Steering Committee. Case 1: A 20-year-old female with SLE and myocarditis Case 2: A 28-year-old woman with SLE, 38 weeks pregnant presents with a headache Disclaimer: ‘During Lupus Academy podcast episodes, participants may refer to off label use of medicines for patients with lupus. Lupus Academy does not make any recommendations about using a medicine outside the terms of its approved licence for use.’

In this episode our host Dr Raquel Faria discusses challenging cases with Professors Ronald van Vollenhoven and Murray Urowitz of the Lupus Academy Steering Committee. Case 1: Refractory serositis Case 2: Acute shrinking lung syndrome Case 3: Uncommon vasculitides in SLE Case 4: An uncommon cause of cardiomyopathy in SLE Disclaimer: ‘During Lupus Academy podcast episodes, participants may refer to off label use of medicines for patients with lupus. Lupus Academy does not make any recommendations about using a medicine outside the terms of its approved licence for use.’

In this episode Dr Raquel Faria is joined by Professors Richard Furie and Zahir Amoura who will be providing expert insights from the key lupus research in 2023. The full report "2023 Year in Review - SLE" can be found in the ⁠⁠⁠Lupus Academy library⁠⁠⁠ Disclaimer: ‘During Lupus Academy podcast episodes, participants may refer to off label use of medicines for patients with lupus. Lupus Academy does not make any recommendations about using a medicine outside the terms of its approved licence for use.’

In this episode our host Dr Raquel Faria discusses research insights and best practices as presented at ACR 2023 with Professors David Isenberg and Richard Furie of the Lupus Academy Steering Committee. The full congress report on SLE highlights presented at ACR 2023 can be found in the ⁠⁠Lupus Academy library⁠⁠ Disclaimer: ‘During Lupus Academy podcast episodes, participants may refer to off label use of medicines for patients with lupus. Lupus Academy does not make any recommendations about using a medicine outside the terms of its approved licence for use.’

In this episode, our host Raquel Faria, will be discussing two challenging lupus cases with Professors Ricard Cervera and David Isenberg from the Lupus Academy Steering Committee. Case 1. A patient admitted with fever, acute pain in the second finger of her right hand and a heart murmur. Case 2. A patient admitted following 6 days of muscle pain in both arms and legs as well as increase in her fatigue and mild fever. Disclaimer: ‘During Lupus Academy podcast episodes, participants may refer to off label use of medicines for patients with lupus. Lupus Academy does not make any recommendations about using a medicine outside the terms of its approved licence for use.’

In this episode our host Dr Raquel Faria discusses the educational highlights of the 12th Annual Meeting of the Lupus Academy with Professors Ricard Cervera and Sandra Navarra, who were Chairs of this meeting. You can link though here to the full report on the meeting. Disclaimer: ‘During Lupus Academy podcast episodes, participants may refer to off label use of medicines for patients with lupus. Lupus Academy does not make any recommendations about using a medicine outside the terms of its approved licence for use.’

In this episode our host, Dr Raquel Faria, will be discussing a challenging lupus case with Professor Ricard Cervera from the Lupus Academy Steering Committee. Disclaimer: ‘During Lupus Academy podcast episodes, participants may refer to off label use of medicines for patients with lupus. Lupus Academy does not make any recommendations about using a medicine outside the terms of its approved licence for use.’

In this episode our host Dr Raquel Faria discusses research insights and the new lupus guidelines as presented at EULAR 2023 with Professors David Isenberg and Richard Furie from the Lupus Academy Steering Committee. The full congress report on SLE highlights presented at EULAR 2023 can be found in the ⁠Lupus Academy library⁠ Disclaimer: ‘During Lupus Academy podcast episodes, participants may refer to off label use of medicines for patients with lupus. Lupus Academy does not make any recommendations about using a medicine outside the terms of its approved licence for use.’

In this episode, our host Dr Raquel Faria, will be discussing two challenging lupus cases with Professors Sandra Navarra and Bernardo Pons- Estel from the Lupus Academy Steering Committee. Case 1: CLE and differential diagnosis Case 2: lupus nephritis and cardiomyopathy with PAH Disclaimer: ‘During Lupus Academy podcast episodes, participants may refer to off label use of medicines for patients with lupus. Lupus Academy does not make any recommendations about using a medicine outside the terms of its approved licence for use.’

In this episode our host Dr Raquel Faria discusses research insights and best practices as presented at the Lupus and KCR 2023 Meeting with Prof Sandra Navarra and Prof Ronald van Vollenhoven of the Lupus Academy Steering Committee. You can link through here to the full report on the 15th International Congress on Systemic Lupus Erythematosus in our library. Disclaimer: ‘During Lupus Academy podcast episodes, participants may refer to off label use of medicines for patients with lupus. Lupus Academy does not make any recommendations about using a medicine outside the terms of its approved licence for use.’

In this episode, our host Dr Raquel Faria, will be speaking with Jeanette Andersen (Chair of Lupus Europe) and Professors Ricard Cervera and Maria Dall'Era from the Lupus Academy Steering Committee about patient perspectives in lupus management. You can visit the Lupus Europe website here: https://www.lupus-europe.org/ Disclaimer: ‘During Lupus Academy podcast episodes, participants may refer to off label use of medicines for patients with lupus. Lupus Academy does not make any recommendations about using a medicine outside the terms of its approved licence for use.’

In this episode, our host Dr Raquel Faria, will be discussing a few challenging lupus cases with Professors Eloisa Bonfa and Murray Urowitz from the Lupus Academy Steering Committee. Case 1: Focal cerebral involvement in SLE Case 2: SLE and recurrent myelitis Case 3: SLE and acute psychosis Case 4: A diagnostic challenge in NPSLE Disclaimer: ‘During Lupus Academy podcast episodes, participants may refer to off label use of medicines for patients with lupus. Lupus Academy does not make any recommendations about using a medicine outside the terms of its approved licence for use.’

In this episode, our host Dr Raquel Faria, will be discussing two challenging lupus cases with Professors Murray Urowitz and David Isenberg from the Lupus Academy Steering Committee. Case 1: Venous thromboembolism and thrombocytopaenia Case 2: A premature atherosclerotic event Disclaimer: ‘During Lupus Academy podcast episodes, participants may refer to off label use of medicines for patients with lupus. Lupus Academy does not make any recommendations about using a medicine outside the terms of its approved licence for use.’

In this episode, our host Raquel Faria, will be discussing two challenging lupus cases with Professors Zahir Amoura and David Isenberg from the Lupus Academy Steering Committee. Case 1. Patient returns from the Congo with heavy proteinuria and fever. Case 2. African female with severe infection and a severe lupus flare. Disclaimer: ‘During Lupus Academy podcast episodes, participants may refer to off label use of medicines for patients with lupus. Lupus Academy does not make any recommendations about using a medicine outside the terms of its approved licence for use.’

In this bonus episode our host, Dr Raquel Faria, is joined by Professors Ricard Cervera and Zahir Amoura who will be providing expert insights from the key lupus research in 2022. For the full written report '2022 Year in Review' please refer to our online library: https://www.lupus-academy.org/library/congress-reports Disclaimer: During Lupus Academy podcast episodes, participants may refer to off label use of medicines for patients with lupus. Lupus Academy does not make any recommendations about using a medicine outside the terms of its approved licence for use. References for this episode: Bruce IN, Furie RA, Morand EF, et al. Concordance and discordance in SLE clinical trial outcome measures: analysis of three anifrolumab phase 2/3 trials. Ann Rheum Dis. 2022;81(7):962-969. Dörner T, van Vollenhoven RF, Doria A, et al. Baricitinib decreases anti-dsDNA in patients with systemic lupus erythematosus: results from a phase II double-blind, randomized, placebo-controlled trial. Arthritis Res Ther. 2022;24(1):112. Furie RA, Aroca G, Cascino MD, et al. B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial. Ann Rheum Dis. 2022;81(1):100-107. Furie RA, Hough DR, Gaudy A, et al. Iberdomide in patients with systemic lupus erythematosus: a randomised, double-blind, placebo-controlled, ascending-dose, phase 2a study. Lupus Sci Med. 2022;9(1). Furie RA, van Vollenhoven RF, Kalunian K, Navarra S, Romero-Diaz J, Werth VP, Huang X, Clark G, Carroll H, Meyers A, Musselli C, Barbey C, Franchimont N; LILAC Trial Investigators. Trial of Anti-BDCA2 Antibody Litifilimab for Systemic Lupus Erythematosus. N Engl J Med. 2022 Sep 8;387(10):894-904. Ginzler E, Guedes Barbosa LS, D'Cruz D, et al. Phase III/IV, Randomized, Fifty-Two-Week Study of the Efficacy and Safety of Belimumab in Patients of Black African Ancestry With Systemic Lupus Erythematosus. Arthritis Rheumatol. 2022;74(1):112-123. Jayne D, Rovin B, Mysler EF, et al. Phase II randomised trial of type I interferon inhibitor anifrolumab in patients with active lupus nephritis. Ann Rheum Dis. 2022;81(4):496-506. Sun L, Shen Q, Gong Y, Li Y, Lv Q, Liu H, Zhao F, Yu H, Qiu L, Li X, He X, Chen Y, Xu Z, Xu H. Safety and efficacy of telitacicept in refractory childhood-onset systemic lupus erythematosus: A self-controlled before-after trial. Lupus. 2022 Jul;31(8):998-1006. van Vollenhoven RF, Hahn BH, Tsokos GC, et al. Efficacy and Safety of Ustekinumab in Patients With Active Systemic Lupus Erythematosus: Results of a Phase II Open-label Extension Study. J Rheumatol. 2022;49(4):380-387.

In this episode Dr Raquel Faria is speaking with Professors Murray Urowitz and Maria Dall'Era of the Lupus Academy Steering Committee. They will be providing expert insights from the key research and clinical data presented at the American College of Rheumatology (ACR) Annual Meeting in November 2022. For the full report on this meeting, please refer to our online library: https://www.lupus-academy.org/library/congress-reports Disclaimer: ‘During Lupus Academy podcast episodes, participants may refer to off label use of medicines for patients with lupus. Lupus Academy does not make any recommendations about using a medicine outside the terms of its approved licence for use.’

In this episode Dr Raquel Faria discusses clinical trials insights and best practices as presented at the 13th European Lupus Meeting with Prof Andrea Doria and Prof Thomas Doerner of the Lupus Academy Steering Committee. For the full report on this meeting, please refer to our online library: https://www.lupus-academy.org/library/congress-reports Disclaimer: ‘During Lupus Academy podcast episodes, participants may refer to off label use of medicines for patients with lupus. Lupus Academy does not make any recommendations about using a medicine outside the terms of its approved licence for use.’

In this episode, our host Raquel Faria, a Doctor in Internal Medicine at the Centro Hospitalar in Porto will be discussing a challenging lupus case with Professors Andrea Doria and Sandra Navarra from the Lupus Academy Steering Committee. Case: Polyarthritis in a Young Woman If you want to see pictures, please visit https://lupus-academy.org/podcast/shownotes Disclaimer: ‘During Lupus Academy podcast episodes, participants may refer to off label use of medicines for patients with lupus. Lupus Academy does not make any recommendations about using a medicine outside the terms of its approved licence for use.’